Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prehospital ceftriaxone for suspected severe sepsis or septic shock
NL-OMON43665Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ceftriaxone in sepsis and septic shock (2 arms), sponsored by Vrije University Medical Center. Primary endpoint: 28-day mortality. Started Jun 2014; status: active, not recruiting.
02
Drugs
ceftriaxone
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NL-OMON43665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43665.